feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

New Stollery Hospital site chosen

trending

Google's Gemini 3 AI model

trending

Travis Turner missing, investigation ongoing

trending

Alabama Power freezes rates

trending

Ukraine peace talks edge forward

trending

Campbell's Soup executive racist remarks

trending

September PPI data release

trending

Alphabet races toward $4 trillion

trending

Farmers Insurance rate hike request

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Diabetes & MASLD: Power Plants Fail Fuel Switch

Diabetes & MASLD: Power Plants Fail Fuel Switch

25 Nov

•

Summary

  • Mitochondria, body's energy producers, struggle to use ketone bodies for fuel.
  • Insulin resistance in type 2 diabetes and MASLD impairs energy generation.
  • Study reveals a new target for improving energy metabolism in these conditions.
Diabetes & MASLD: Power Plants Fail Fuel Switch

Researchers have uncovered a critical energy metabolism issue affecting individuals with type 2 diabetes and MASLD. Mitochondria, essential for cellular energy, were found to be less efficient at utilizing ketone bodies, a key fuel source derived from fat breakdown. This impaired ability to switch between energy sources is particularly detrimental in states of insulin resistance.

The study utilized a novel high-resolution respirometry technique to directly assess mitochondrial energy generation from ketone bodies. Findings indicated a marked decrease in this process across various insulin-resistant conditions. Specifically, heart and skeletal muscle cells in type 2 diabetes patients, and liver cells in MASLD patients, demonstrated significantly reduced energy output from ketone metabolism.

These discoveries point towards a potential new therapeutic target for improving energy metabolism in diabetes and MASLD. The vulnerability of ketone body metabolism in insulin resistance suggests that interventions focused on enhancing this pathway could offer significant benefits for patients. The research highlights the complex interplay between fuel availability and mitochondrial function.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
In type 2 diabetes, mitochondria struggle to effectively switch between fuel sources, particularly impacting their ability to use ketone bodies for energy.
Metabolic dysfunction-associated steatotic liver disease (MASLD) impairs mitochondrial function, leading to decreased energy generation from ketone bodies in liver cells.
Ketone bodies are molecules derived from fatty acids that serve as an alternative fuel source for organs when glucose is scarce, crucial for energy production.

Read more news on

Healthside-arrow

You may also like

Buttock Shape Reveals Health Clues

12 hours ago

Hidden Fat Fuels Brain Aging, Alzheimer's Risk

1 day ago • 5 reads

article image

Health Gaps Plague India's Chronic Care

1 day ago • 2 reads

article image

Sudden Diabetes: Your Pancreas Is Signaling Danger

23 Nov • 4 reads

GLP-1s: More Than Just Weight Loss?

21 Nov • 24 reads